<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Daily Stocks News &#187; VRTX</title>
	<atom:link href="http://news.dailystocks.com/tag/vrtx/feed/" rel="self" type="application/rss+xml" />
	<link>http://news.dailystocks.com</link>
	<description>Stocks with Insider Buying, Stock Search Engine, Glossary, Education, Reviews</description>
	<lastBuildDate>Mon, 21 Jan 2019 17:42:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Major Movers on April 19; RH, VRTX, IBM, ACTG, MSFT, EFII</title>
		<link>http://news.dailystocks.com/2821/major-movers-on-april-19-rh-vrtx-ibm-actg-msft-efii/</link>
		<comments>http://news.dailystocks.com/2821/major-movers-on-april-19-rh-vrtx-ibm-actg-msft-efii/#comments</comments>
		<pubDate>Fri, 19 Apr 2013 18:25:02 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[ACTG]]></category>
		<category><![CDATA[EFII]]></category>
		<category><![CDATA[IBM]]></category>
		<category><![CDATA[MSFT]]></category>
		<category><![CDATA[RH]]></category>
		<category><![CDATA[VRTX]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=2821</guid>
		<description><![CDATA[<p>Restoration Hardware Holdings Inc. (NYSE: RH) skyrocketed about 20% by midday trading after the home furnisher, late last evening reported very strong fiscal fourth quarter results and provided upbeat guidance on the fiscal first quarter and full-year. The Company reported earnings of 64 cents a share, while analysts’ consensus estimate was for earnings of 60 [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/2821/major-movers-on-april-19-rh-vrtx-ibm-actg-msft-efii/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vertex Pharmaceuticals Shares Soar over VX-661 Mid-Stage Results (VRTX)</title>
		<link>http://news.dailystocks.com/2815/vertex-pharmaceuticals-shares-soar-over-vx-661-mid-stage-results-vrtx/</link>
		<comments>http://news.dailystocks.com/2815/vertex-pharmaceuticals-shares-soar-over-vx-661-mid-stage-results-vrtx/#comments</comments>
		<pubDate>Fri, 19 Apr 2013 10:29:31 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[VRTX]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=2815</guid>
		<description><![CDATA[<p>Shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) skyrocketed 52.26% during afterhours trading on Thursday after the company said that mid-stage clinical trial of its unbranded treatment called VX-661 showed significant improvements in lung functions among adults.</p> <p></p> <p>Although the drug has to go a long way before it can potentially hit the market, the results [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/2815/vertex-pharmaceuticals-shares-soar-over-vx-661-mid-stage-results-vrtx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vertex Pharmaceuticals Shares Surge on Encouraging Clinical Data (VRTX)</title>
		<link>http://news.dailystocks.com/219/vertex-pharmaceuticals-shares-surge-on-encouraging-clinical-data-vrtx/</link>
		<comments>http://news.dailystocks.com/219/vertex-pharmaceuticals-shares-surge-on-encouraging-clinical-data-vrtx/#comments</comments>
		<pubDate>Tue, 08 May 2012 07:07:21 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[VRTX]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=219</guid>
		<description><![CDATA[<p>Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a biotechnology company engaged in the discovery, development, manufacturing and commercialization of small molecule drugs for the treatment of serious diseases, on Monday, reported that the new cystic fibrosis drug Kalydeco when combined with its experimental treatment for the disease led to substantially improved breathing ability in a mid-stage study.</p> [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/219/vertex-pharmaceuticals-shares-surge-on-encouraging-clinical-data-vrtx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
